Breaking News, Collaborations & Alliances

Biogen, Columbia Form Genetics Discovery Alliance

Aims to identify new treatment approaches for diseases with significant unmet need

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Biogen Idec and Columbia University Medical Center have formed a $30 million strategic alliance to conduct genetics discovery research on the underlying causes of disease and to identify new treatment approaches. A sequencing and analysis facility and shared postdoctoral program will be established at Columbia to support collaborative genetics studies. The agreement will integrate genomics research conducted at Columbia with Biogen’s understanding of disease mechanisms and pathways, and expertis...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters